CA1210008A - Organometal complexes of n-cyclohexyl-piperazino acetamides or proprionamides, preparation and use thereof as antiulcer-antisecretive-buffering drugs - Google Patents
Organometal complexes of n-cyclohexyl-piperazino acetamides or proprionamides, preparation and use thereof as antiulcer-antisecretive-buffering drugsInfo
- Publication number
- CA1210008A CA1210008A CA000417103A CA417103A CA1210008A CA 1210008 A CA1210008 A CA 1210008A CA 000417103 A CA000417103 A CA 000417103A CA 417103 A CA417103 A CA 417103A CA 1210008 A CA1210008 A CA 1210008A
- Authority
- CA
- Canada
- Prior art keywords
- cyclohexyl
- piperazino
- acetamide
- dihydroxy
- aluminum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940079593 drug Drugs 0.000 title abstract description 3
- 239000003814 drug Substances 0.000 title abstract description 3
- 238000002360 preparation method Methods 0.000 title description 2
- 150000003869 acetamides Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- RTFADALJKSFJDZ-UHFFFAOYSA-N n-cyclohexyl-2-piperazin-1-ylacetamide Chemical class C1CCCCC1NC(=O)CN1CCNCC1 RTFADALJKSFJDZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical class CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- HDVDLQFPDLTOSI-UHFFFAOYSA-L O[AlH]O Chemical compound O[AlH]O HDVDLQFPDLTOSI-UHFFFAOYSA-L 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- YMILRBLJDGKUDX-CXKLNRRHSA-K aluminum;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;dihydroxide Chemical compound O[Al+]O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O YMILRBLJDGKUDX-CXKLNRRHSA-K 0.000 claims description 5
- 229940080818 propionamide Drugs 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 3
- 235000012208 gluconic acid Nutrition 0.000 claims description 3
- 239000000174 gluconic acid Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 claims description 2
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 2
- 238000001704 evaporation Methods 0.000 claims 1
- 239000012299 nitrogen atmosphere Substances 0.000 claims 1
- 239000011541 reaction mixture Substances 0.000 claims 1
- 230000000767 anti-ulcer Effects 0.000 description 5
- 230000003139 buffering effect Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- -1 cyclohexyl-piperazino Chemical group 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020601 Hyperchlorhydria Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- UQMLCXLXBOIRHH-UHFFFAOYSA-N n-(4-cyclohexylpiperazin-1-yl)acetamide Chemical compound C1CN(NC(=O)C)CCN1C1CCCCC1 UQMLCXLXBOIRHH-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 125000006699 (C1-C3) hydroxyalkyl group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical group C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- ICPMTQOYWXXMIG-OPDGVEILSA-K aluminum;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Al+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O ICPMTQOYWXXMIG-OPDGVEILSA-K 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000000490 cinnamyl group Chemical group C(C=CC1=CC=CC=C1)* 0.000 description 1
- 238000003926 complexometric titration Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- YBKJHGLBSIEZGO-UHFFFAOYSA-N n-cyclohexyl-n-piperazin-1-ylacetamide Chemical compound C1CNCCN1N(C(=O)C)C1CCCCC1 YBKJHGLBSIEZGO-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- 150000007530 organic bases Chemical group 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/10—Polyhydroxy carboxylic acids
- C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/06—Aluminium compounds
- C07F5/069—Aluminium compounds without C-aluminium linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20583A/82 | 1982-04-05 | ||
| IT20583/82A IT1150759B (it) | 1982-04-05 | 1982-04-05 | Complessi organometallici di n-cicloesil-piperazino-acetammidi o propionammidi, loro preparazione e impiego come farmaci antiulcera-antisecretivi-tamponanti |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1210008A true CA1210008A (en) | 1986-08-19 |
Family
ID=11169140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000417103A Expired CA1210008A (en) | 1982-04-05 | 1982-12-06 | Organometal complexes of n-cyclohexyl-piperazino acetamides or proprionamides, preparation and use thereof as antiulcer-antisecretive-buffering drugs |
Country Status (8)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3218394B2 (ja) * | 1999-09-03 | 2001-10-15 | 西川ゴム工業株式会社 | 自動車ドア下部のシール構造 |
| US8202830B2 (en) | 2009-01-30 | 2012-06-19 | Ecolab Usa Inc. | Development of an aluminum hydroxydicarboxylate builder |
| BRPI1006847B1 (pt) * | 2009-01-30 | 2019-11-26 | Ecolab Inc | composição de limpeza para remover sujeiras, composição detergente e método de remoção de sujeiras |
| WO2011000945A2 (en) | 2009-07-03 | 2011-01-06 | Nensius Research A/S | Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| US8536106B2 (en) | 2010-04-14 | 2013-09-17 | Ecolab Usa Inc. | Ferric hydroxycarboxylate as a builder |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB779504A (en) * | 1954-03-11 | 1957-07-24 | American Cyanamid Co | Tetracycline antibiotic complexes |
| US2910493A (en) * | 1955-12-28 | 1959-10-27 | J W Ayers & Co | Hydroxy-, alkoxy-aluminum salts of aliphatic amino acids |
| US3542919A (en) * | 1956-06-04 | 1970-11-24 | Wickhen Products Inc | Astringent alkali metal aluminum complexes of hydroxy acids |
| GB1086502A (en) * | 1964-07-17 | 1967-10-11 | Rech S Scient Et D Expl De Mar | New organometallic or organoboron complexes of tris-(hydroxymethyl) amino-methane and process for preparing the same |
| US3629229A (en) * | 1969-02-27 | 1971-12-21 | Chatten Drug & Chem Co | Water soluble basic aluminum polyhydroxyl hydrocarbon complexes |
| GB1397407A (en) * | 1971-07-06 | 1975-06-11 | Hardman & Holden Ltd | Aluminium containing pharmaceutical compounds |
| CH619960A5 (en) * | 1974-05-22 | 1980-10-31 | Scharper Spa | Process for the preparation of tris(hydroxymethyl)-aminomethane-gluconate dihydroxy-aluminate |
| IT1043871B (it) * | 1974-05-22 | 1980-02-29 | Scharper Spa | Procedimento di preparazione industriale di tris idhossimeil aminometan gluconato diiurossi alluminato |
| IT1054961B (it) * | 1976-01-23 | 1981-11-30 | Corvi Camillo Spa | Derivati della piperazina adatti come agenti anti ulcera |
| IT1081804B (it) * | 1977-06-07 | 1985-05-21 | Scharper Spa | Procedimento di preparazione di tris (idrossimetil)-aminometan-lattato-diidrossialluminato |
-
1982
- 1982-04-05 IT IT20583/82A patent/IT1150759B/it active
- 1982-12-06 CA CA000417103A patent/CA1210008A/en not_active Expired
- 1982-12-14 GB GB08235607A patent/GB2117756B/en not_active Expired
- 1982-12-22 FR FR8221529A patent/FR2524470B1/fr not_active Expired
-
1983
- 1983-01-11 ES ES518901A patent/ES8402593A1/es not_active Expired
- 1983-01-13 JP JP58002932A patent/JPS58177998A/ja active Pending
- 1983-01-31 US US06/462,138 patent/US4495186A/en not_active Expired - Fee Related
- 1983-03-23 DE DE19833310584 patent/DE3310584A1/de active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE3310584C2 (US20110009641A1-20110113-C00273.png) | 1987-07-09 |
| GB2117756B (en) | 1986-07-02 |
| ES518901A0 (es) | 1984-03-01 |
| ES8402593A1 (es) | 1984-03-01 |
| JPS58177998A (ja) | 1983-10-18 |
| IT8220583A0 (it) | 1982-04-05 |
| US4495186A (en) | 1985-01-22 |
| DE3310584A1 (de) | 1983-10-13 |
| FR2524470A1 (fr) | 1983-10-07 |
| FR2524470B1 (fr) | 1985-10-25 |
| GB2117756A (en) | 1983-10-19 |
| IT1150759B (it) | 1986-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100381644B1 (ko) | 안정성이우수한8-알콕시퀴놀론카복실산수화물및이의제조방법 | |
| PL170787B1 (en) | Method of obtaining an organic salt and n,n'-diacetlocystine | |
| CZ288657B6 (cs) | Nová krystalová modifikace hydrochloridu 1-cyklopropyl-7-([S,S]-2,8-diazabicyklo[4.3.0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolinkarboxylové kyseliny, způsob její výroby a použití pro výrobu léčiv | |
| CA1210008A (en) | Organometal complexes of n-cyclohexyl-piperazino acetamides or proprionamides, preparation and use thereof as antiulcer-antisecretive-buffering drugs | |
| GB1567958A (en) | Piperazine and piperazine homologue derivatives and preparation and use thereof | |
| EP0028698B1 (en) | Quinoline compounds, process for their preparation, and pharmaceutical compositions | |
| DE3780382T2 (de) | Metall komplexe von n-methyl-11-aza-10-deoxy-10-dihydroerythromycin-a oder von 11-aza-10-deoxy-10-dihydroxyerythromycin-a, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen praeparaten. | |
| EP0193965B1 (en) | Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them | |
| KR880001477B1 (ko) | 니플룸산 모르폴리노에틸에스테르 디니플루메이트의 제조방법 | |
| KR19990025064A (ko) | 4급 암모늄 인산염 화합물 및 그 제조방법 | |
| US4013699A (en) | Aluminium and/or magnesium salts of amino-acids | |
| EP0185368B1 (en) | Aminobenzamide derivatives | |
| US4076745A (en) | Process for calcium salts α-ketocarboxylic acids | |
| US4450274A (en) | Preparation of ethambutol-diisoniazide methane sulfonic acid salt | |
| WO2001051460A1 (en) | NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | |
| EP0215639B1 (en) | Propionamidine derivatives | |
| RU2160255C2 (ru) | Способ превращения замещенных 8-хлорхинолинов в замещенные 8-гидроксихинолины | |
| US5126456A (en) | 7-chloroquinaldine synthesis | |
| EP0154173B1 (en) | Pteridine derivatives, an anticancer composition containing same and a process for the production of said derivatives | |
| SU1456016A3 (ru) | Способ получени имидазолсодержащих соединений или их кислотно-аддитивных солей | |
| KR840000522B1 (ko) | 퀴놀린 화합물의 제조방법 | |
| KR0149635B1 (ko) | 디알킬 디클로로숙시네이트의 개선된 제조방법 | |
| SU1213726A1 (ru) | 3-Диметиламинопропиламид бензтиазино[2,3-в]фенотиазин-6-карбоновой кислоты, обладающий противоопухолевой активностью | |
| JPS6419069A (en) | Production of polyhalogenoquinoline derivative | |
| US4016272A (en) | Anthelmintic thiodiphenylamine cupric chloride complex salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |